Search - tctmd.com

Displaying 561 - 580 of 696

Sort: Relevancy | Date

Presentation SOLACI 2013

Technologies for Embolic Prevention in STEMI PCI

Presenter: David Antoniucci

July 24, 2013

News Daily News

Most Recurrent Ischemic Events After PFO Closure Related to Comorbidities

July 24, 2013

News Daily News

La Mayoría de Episodios Isquémicos Recurrentes tras el Cierre del FOP se asocian a Comorbilidades

July 24, 2013

News Daily News

Several Predictors Found for Cerebral Embolization After Protected Carotid Stenting

Yael L. Maxwell

June 28, 2013

News Daily News

Se Hallan Varios Predictores de la Embolización Cerebral tras Implantar Stents Carotídeos Protegidos

Yael L. Maxwell

June 28, 2013

Presentation TVT 2013

Cerebral Embolic Protection Devices

Presenter: Eberhard Grube

June 14, 2013

Presentation

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

Presenter: L. Bijuklic

June 06, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

News Daily News

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Yael L. Maxwell

May 17, 2013

News Daily News

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Yael L. Maxwell

May 17, 2013

Presentation

Histopathology of Embolic Debris Captured During TAVR

Presenter: Nicolas M. Van Mieghem

May 16, 2013

News Daily News

Population-Based Study Fails to Link PFOs to Increased Risk of CV Events

L.A. McKeown

May 03, 2013

News Daily News

Estudio demográfico no asocia los PFO al aumento del riesgo de episodios cerebrovasculares

L.A. McKeown

May 03, 2013

Presentation Fellows 2013

Thrombectomy and Embolic Protection Systems

Presenter: Manish Parikh

April 16, 2013

News Daily News

Silent Lesions Common after CAS, but Do Not Impact Hard Events

April 05, 2013

News Daily News

Las Lesiones Silenciosas son Frecuentes tras la CAS pero No Influyen en los Episodios Objetivos

April 05, 2013

News Industry News

Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter

February 12, 2013

Presentation TCT 2013

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Presenter: Isabelle Henry, Amira BENJELLOUN, Michel Henry

January 31, 2013

Presentation TCT 2013

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Presenter: Amir Ravandi, Gregor Leibundgut, Patrick Hu, Anand Prasad, Brian Kolski, Bahram Khadivi, Mitul Patel, Ehtisham Mahmud, Yury Miller, Edward Dennis, Joseph Witztum, Sotirios Tsimikas

January 31, 2013

Advertisement

Technologies for Embolic Prevention in STEMI PCI

Most Recurrent Ischemic Events After PFO Closure Related to Comorbidities

La Mayoría de Episodios Isquémicos Recurrentes tras el Cierre del FOP se asocian a Comorbilidades

Several Predictors Found for Cerebral Embolization After Protected Carotid Stenting

Se Hallan Varios Predictores de la Embolización Cerebral tras Implantar Stents Carotídeos Protegidos

Cerebral Embolic Protection Devices

Risk Factors for Cerebral Embolization After CAS With Embolic Protection

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Residuos Embólicos Capturados por Filtros en ¾ partes de los Pacientes TAVR

Embolic Debris Captured by Filters in Three-Quarters of TAVR Patients

Histopathology of Embolic Debris Captured During TAVR

Population-Based Study Fails to Link PFOs to Increased Risk of CV Events

Estudio demográfico no asocia los PFO al aumento del riesgo de episodios cerebrovasculares

Thrombectomy and Embolic Protection Systems

Silent Lesions Common after CAS, but Do Not Impact Hard Events

Las Lesiones Silenciosas son Frecuentes tras la CAS pero No Influyen en los Episodios Objetivos

Loma Vista Medical reports that it is ramping up sales in U.S. and Europe of its FDA-cleared and CE-marked TRUE Dilatation™ Balloon Valvuloplasty Catheter

Renal Angioplasty And Stenting. Limitations. Role Of Embolic Protection Devices

Release of Bioactive Lipids During Percutaneous Coronary, and Peripheral Arterial Interventions in Humans: Lipidomic analysis of Distal Embolic Protection Devices.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content